hVIVO plc (LON:HVO – Get Free Report)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 28.06 ($0.35) and traded as high as GBX 28.10 ($0.35). hVIVO shares last traded at GBX 27.95 ($0.35), with a volume of 472,093 shares.
hVIVO Stock Up 0.2 %
The company has a quick ratio of 1.16, a current ratio of 1.46 and a debt-to-equity ratio of 9.83. The firm has a market cap of £190.50 million, a P/E ratio of -1.00 and a beta of 0.99. The business has a fifty day moving average of GBX 28.08 and a 200 day moving average of GBX 24.89.
hVIVO Cuts Dividend
The company also recently declared a dividend, which will be paid on Monday, May 20th. Investors of record on Thursday, April 18th will be given a GBX 0.20 ($0.00) dividend. The ex-dividend date is Thursday, April 18th. This represents a dividend yield of 0.68%.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- Best Aerospace Stocks Investing
- MarketBeat Week in Review – 4/29 – 5/3
- Which Wall Street Analysts are the Most Accurate?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- The Role Economic Reports Play in a Successful Investment Strategy
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
